Evidence map›Paper›PMID 12704111›Full record

ArticleInfection and immunity2003

LipL21 is a novel surface-exposed lipoprotein of pathogenic Leptospira species.

Paul A Cullen, David A Haake, Dieter M Bulach, Richard L Zuerner, Ben Adler

Abstract read
In one paragraph

Article in Infection and immunity, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Advances in the development of a vaccine for the prevention of human leptospirosis: a review.Revista do Instituto de Medicina Tropical de Sao Paulo · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Evaluation ofFrontiers in microbiology · 2023
    Article
  7. Review
  8. Screening of Surface-Exposed Lipoproteins ofFrontiers in microbiology · 2022
    Article
  9. Host and Species-Specificities of Pattern Recognition Receptors Upon Infection WithFrontiers in cellular and infection microbiology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Human leptospirosis vaccines in China.Human vaccines & immunotherapeutics · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. The leptospiral outer membrane.Current topics in microbiology and immunology · 2015
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Paul A CullenBacterial Pathogenesis Research Group, Department of Microbiology, Monash University, Melbourne, Victoria 3800, Australia.
David A Haake
Dieter M Bulach
Richard L Zuerner
Ben Adler
Monash University · AUNational Animal Disease Center · USUniversity of California, Los Angeles · US

Funding

Outer Membrane Proteins of Pathogenic Leptospira SpeciesR01AI034431 · NIAID · BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE · PI GOMES-SOLECKI, MARIA, HAAKE, DAVID A · 2003 to 2015
$4.1M
OUTER MEMBRANE PROTEINS OF PATHOGENIC LEPTOSPIRA SPECIESR21AI034431 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HAAKE, DAVID A · 2001 to 2001
$252k
OUTER MEMBRANE PROTEINS OF PATHOGENIC LEPTOSPIRA SPECIESR29AI034431 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HAAKE, DAVID A · 1996 to 2000
$91k
NIAID NIH HHS AI-34431NIAID NIH HHS R01 AI034431NIAID NIH HHS R21 AI034431NIAID NIH HHS R29 AI034431
6 · The paper itself

Abstract

Leptospira is the etiologic agent of leptospirosis, a bacterial zoonosis distributed worldwide. Leptospiral lipopolysaccharide is a protective immunogen, but the extensive serological diversity of leptospires has inspired a search for conserved outer membrane proteins (OMPs) that may stimulate heterologous immunity. Previously, a global analysis of leptospiral OMPs (P. A. Cullen, S. J. Cordwell, D. M. Bulach, D. A. Haake, and B. Adler, Infect. Immun. 70:2311-2318, 2002) identified pL21, a novel 21-kDa protein that is the second most abundant constituent of the Leptospira interrogans serovar Lai outer membrane proteome. In this study, we identified the gene encoding pL21 and found it to encode a putative lipoprotein; accordingly, the protein was renamed LipL21. Southern hybridization analysis revealed the presence of lipL21 in all of the pathogenic species but in none of the saprophytic species examined. Alignment of the LipL21 sequence from six strains of Leptospira revealed 96 to 100% identity. When specific polyclonal antisera to recombinant LipL21 were used, LipL21 was isolated together with other known leptospiral OMPs by both Triton X-114 extraction and sucrose density gradient membrane fractionation. All nine strains of pathogenic leptospires investigated by Western blotting, whether culture attenuated or virulent, were found to express LipL21. In contrast, the expression of LipL21 or an antigenically related protein could not be detected in nonpathogenic L. biflexa. Infected hamster sera and two of eight human leptospirosis sera tested were found to react with recombinant LipL21. Native LipL21 was found to incorporate tritiated palmitic acid, consistent with the prediction of a lipoprotein signal peptidase cleavage site. Biotinylation of the leptospiral surface resulted in selective labeling of LipL21 and the previously known OMPs LipL32 and LipL41. These findings show that LipL21 is a surface-exposed, abundant outer membrane lipoprotein that is expressed during infection and conserved among pathogenic Leptospira species.

Indexed as

AnimalsBacterial ProteinsCricetinaeHumansImmune SeraLeptospiraLipoproteinsMesocricetusRabbitsBacterial ProteinsImmune SeraLipoproteins

Identifiers

PMID12704111
PMCPMC153295
OpenAlexW2113489977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.